Emmanuel Papadakis

Stock Analyst at Deutsche Bank

(0.66)
# 3,364
Out of 4,667 analysts
41
Total ratings
33.33%
Success rate
-7.72%
Average return

Stocks Rated by Emmanuel Papadakis

BioNTech SE
Sep 19, 2024
Maintains: Buy
Price Target: $95$150
Current: $102.14
Upside: +46.86%
Moderna
Aug 6, 2024
Upgrades: Hold
Price Target: $85$80
Current: $36.94
Upside: +116.57%
Grifols
Mar 12, 2024
Downgrades: Sell
Price Target: n/a
Current: $8.60
Upside: -
AstraZeneca
Feb 8, 2024
Downgrades: Hold
Price Target: n/a
Current: $63.20
Upside: -
Alvotech
Mar 7, 2023
Maintains: Hold
Price Target: $8$12
Current: $12.42
Upside: -3.38%
Sanofi
Aug 12, 2022
Upgrades: Hold
Price Target: n/a
Current: $47.78
Upside: -
Novo Nordisk
Mar 16, 2022
Upgrades: Buy
Price Target: n/a
Current: $105.27
Upside: -
CureVac
Oct 22, 2021
Initiates: Hold
Price Target: $35
Current: $2.49
Upside: +1,305.62%
Novartis AG
Sep 20, 2021
Downgrades: Sell
Price Target: n/a
Current: $103.09
Upside: -
argenx SE
Jul 23, 2021
Initiates: Hold
Price Target: n/a
Current: $591.82
Upside: -
Downgrades: Sell
Price Target: n/a
Current: $33.35
Upside: -